Stock Research for AMRN

AMRN

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

AMRN Stock Chart & Research Data

The AMRN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AMRN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


AMRN Due diligence Resources & Stock Charts

The AMRN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AMRN Detailed Price Forecast - CNN Money CNN View AMRN Detailed Summary - Google Finance
Yahoo View AMRN Detailed Summary - Yahoo! Finance Zacks View AMRN Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View AMRN Trends & Analysis - Trade-Ideas Barrons View AMRN Major Holders - Barrons
NASDAQ View AMRN Call Transcripts - NASDAQ Seeking View AMRN Breaking News & Analysis - Seeking Alpha
Spotlight View AMRN Annual Report - CompanySpotlight.com OTC Report View AMRN OTC Short Report - OTCShortReport.com
TradeKing View AMRN Fundamentals - TradeKing Charts View AMRN SEC Filings - Bar Chart
WSJ View Historical Prices for AMRN - The WSJ Morningstar View Performance/Total Return for AMRN - Morningstar
MarketWatch View the Analyst Estimates for AMRN - MarketWatch CNBC View the Earnings History for AMRN - CNBC
StockMarketWatch View the AMRN Earnings - StockMarketWatch MacroAxis View AMRN Buy or Sell Recommendations - MacroAxis
Bullish View the AMRN Bullish Patterns - American Bulls Short Pains View AMRN Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View AMRN Stock Mentions - StockTwits PennyStocks View AMRN Stock Mentions - PennyStockTweets
Twitter View AMRN Stock Mentions - Twitter Invest Hub View AMRN Investment Forum News - Investor Hub
Yahoo View AMRN Stock Mentions - Yahoo! Message Board Seeking Alpha View AMRN Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for AMRN - SECform4.com Insider Cow View Insider Transactions for AMRN - Insider Cow
CNBC View AMRN Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AMRN - OTC Markets
Yahoo View Insider Transactions for AMRN - Yahoo! Finance NASDAQ View Institutional Holdings for AMRN - NASDAQ


Stock Charts

FinViz View AMRN Stock Insight & Charts - FinViz.com StockCharts View AMRN Investment Charts - StockCharts.com
BarChart View AMRN Stock Overview & Charts - BarChart Trading View View AMRN User Generated Charts - Trading View


Latest Financial News for AMRN

Is the Options Market Predicting a Spike in Amarin (AMRN) Stock?
Posted on Friday June 22, 2018

Investors in Amarin (AMRN) need to pay close attention to the stock based on moves in the options market lately.


Amarin and Mochida Announce Collaboration on Future Development of EPA-based Drug Products and Indications
Posted on Tuesday June 12, 2018

Amarin Corporation plc (AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that it has entered into a multi-faceted collaboration with Mochida Pharmaceutical Co., Ltd. (“Mochida”, TYO:4534), an integrated Japanese pharmaceutical company. The collaboration is focused on the development and commercialization of early-stage drug products and indications based on the omega-3 acid, EPA (eicosapentaenoic acid). Amarin and Mochida are recognized worldwide as the leading, innovation-driven companies committed to the research and development of EPA-based drug products to treat the needs of tens of millions of patients who are at-risk of cardiovascular disease.


Amarin Sponsors Three Scientific Presentations Scheduled for American Diabetes Association Scientific Sessions
Posted on Thursday June 07, 2018

BEDMINSTER, N.J. and DUBLIN, Ireland, June 07, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...


Research Report Identifies Diodes, Arbutus Biopharma, Radware, Immutep, Amarin, and SPS Commerce with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
Posted on Wednesday June 06, 2018

NEW YORK, June 06, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Diodes ...


Enter a stock symbol to view the stock details.